🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
38297
CAS Number:
58-46-8
Tetrabenazina
Purity:
≥ 99 % (HPLC)
Synonym(s):
3-Isobutil-9,10-dimetoxi-1,3,4,6,7,11b-hexahidro- 2H -benzo[a]quinolizin-2-ona
Documents
$232.25 /200 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
3-Isobutil-9,10-dimetoxi-1,3,4,6,7,11b-hexahidro- 2H -benzo[a]quinolizin-2-ona
CAS Number
58-46-8
Purity
≥ 99 % (HPLC)
Molecular Formula
C 19 H 27 N º 3
Molecular Weight
317.43
MDL Number
MFCD08461052
PubChem ID
6018
Melting Point
124 - 130 °C
Appearance
Polvo de color blanco a amarillo claro hasta cristal.
Conditions
Conservar entre 2 y 8 °C.
General Information
Synonyms
3-Isobutil-9,10-dimetoxi-1,3,4,6,7,11b-hexahidro- 2H -benzo[a]quinolizin-2-ona
CAS Number
58-46-8
Purity
≥ 99 % (HPLC)
Molecular Formula
C 19 H 27 N º 3
Molecular Weight
317.43
MDL Number
MFCD08461052
PubChem ID
6018
Melting Point
124 - 130 °C
Appearance
Polvo de color blanco a amarillo claro hasta cristal.
Conditions
Conservar entre 2 y 8 °C.
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Tetrabenazine is widely utilized in research focused on:

  • Neurological Disorders: Primarily used in the treatment of movement disorders such as Huntington's disease and tardive dyskinesia, helping to reduce involuntary movements.
  • Pharmaceutical Development: Serves as a valuable compound in drug formulation studies, particularly in understanding the pharmacokinetics and pharmacodynamics of similar neuroleptic agents.
  • Research on Monoamine Depletion: Acts as a model compound for studying the effects of monoamine depletion in various neurological studies, aiding researchers in understanding mood disorders.
  • Clinical Trials: Frequently involved in clinical trials aimed at evaluating new therapies for movement disorders, providing a benchmark for efficacy and safety.
  • Custom Compounding: Used in compounding pharmacies to create personalized medication regimens for patients with specific needs, ensuring tailored treatment options.

Citas